Concessão da patente
#16.1
Prazo de Validade: 20 (vinte) anos contados a partir de 30/07/2018, observadas as condições legais
06/18/2024
RPI 2789
Application data
Number
122021014832Type
Filing
Publication
PCT
US2018044324 The patent was granted on 06/18/2024 and is in force until 07/30/2033. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.
Protection valid until:07/30/2033
Latest action published by the INPI: 06/18/2024. We update with every new RPI gazette, published weekly.
Applicants
SHIRE HUMAN GENETIC THERAPIES, INC
US
TAKEDA PHARMACEUTICAL COMPANY LIMITED
JP
Inventors
M. T. (pessoa física)
US
R. S. (pessoa física)
US
R. T. (pessoa física)
US
V. T. (pessoa física)
US
Y. L. (pessoa física)
US
IPC Classification
Priority claims
US
62/541,601 · 08/04/2017
Publications in the Brazilian Industrial Property Gazette (RPI).
#16.1
Prazo de Validade: 20 (vinte) anos contados a partir de 30/07/2018, observadas as condições legais
06/18/2024
RPI 2789
#9.1
03/12/2024
RPI 2775
#7.1
09/12/2023
RPI 2749
#25.1
03/21/2023
RPI 2724
#6.23
06/14/2022
RPI 2684
#15.35
11/03/2021
RPI 2652
#2.4
08/17/2021
RPI 2641
#2.10
Número de Protocolo '870210068447' em 28/07/2021 10:24 (WB)
08/10/2021
RPI 2640
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.